Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
The 10 Most Persuasive Forerunners in Innovation - 2What to know about the hepatitis B shot — and why Trump officials are targeting it
- 3Disney's latest short film 'Versa' tackles a difficult subject: Pregnancy loss. It's resonating with viewers.
- 4Monetary Strengthening: Assuming Command over Your Cash
- 5Steinmeier honours Italian 'guest workers' who rebuilt German economy
- The most effective method to Arrange a Higher Medical caretaker Pay During Your Next New employee screening
- Spain breaks jobs record with 22 million Social Security contributors
- Flu cases skyrocket in US. See cases, where people got sick.
- Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground
- Famous Kitchen Finishing Styles For 2024
- Real time features for Films and Programs
- New dinosaur tracks in Italy illustrate herds moving in unison
- A Manual for Extravagant Vehicles Available in 2024
- Building a Flourishing Business: Illustrations from Business people
